Showing results (1231-1240 of 1,261) with videos related to
Sort By:
Pageof 127
Biorxiv : the Preprint Server for Biology|April 10, 2026
A Genetically Engineered Human Organoid Model Reveals Distinct Genetic and Epigenetic Barriers of Lineage Plasticity in Early PDAC TransformationXian Zhang, Wilfred Wong, Hyein S Cho, et al.The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine|September 10, 2014
Predictors of outcome at 1 year in adolescents with DSM-5 restrictive eating disorders: report of the national eating disorders quality improvement collaborativeSara F Forman, Nicole McKenzie, Rebecca Hehn, et al.Bioorganic & Medicinal Chemistry Letters|December 22, 2005
Potent 2-[(pyrimidin-4-yl)amine}-1,3-thiazole-5-carbonitrile-based inhibitors of VEGFR-2 (KDR) kinaseJohn T Sisko, Thomas J Tucker, Mark T Bilodeau, et al.Bioorganic & Medicinal Chemistry Letters|September 1, 2007
Kinesin spindle protein (KSP) inhibitors. Part 6: Design and synthesis of 3,5-diaryl-4,5-dihydropyrazole amides as potent inhibitors of the mitotic kinesin KSPPaul J Coleman, John D Schreier, Christopher D Cox, et al.Bioorganic & Medicinal Chemistry Letters|April 9, 2015
Tricyclic 1,5-naphthyridinone oxabicyclooctane-linked novel bacterial topoisomerase inhibitors as broad-spectrum antibacterial agents-SAR of left-hand-side moiety (Part-2)Sheo B Singh, David E Kaelin, Jin Wu, et al.Heart Rhythm|December 15, 2024
Novel risk predictor of arrhythmias for patients with potassium channel-related congenital long QT syndromeChristian Krijger Juárez, Virginnio M Proost, Michael W Tanck, et al.Journal of Medicinal Chemistry|February 6, 2013
Discovery of 1-[3-(1-methyl-1H-pyrazol-4-yl)-5-oxo-5H-benzo[4,5]cyclohepta[1,2-b]pyridin-7-yl]-N-(pyridin-2-ylmethyl)methanesulfonamide (MK-8033): A Specific c-Met/Ron dual kinase inhibitor with preferential affinity for the activated state of c-MetAlan B Northrup, Matthew H Katcher, Michael D Altman, et al.Journal of Medicinal Chemistry|June 11, 2014
Maximizing diversity from a kinase screen: identification of novel and selective pan-Trk inhibitors for chronic painShawn J Stachel, John M Sanders, Darrell A Henze, et al.Bioorganic & Medicinal Chemistry Letters|September 19, 2006
3-(Indol-2-yl)indazoles as Chek1 kinase inhibitors: Optimization of potency and selectivity via substitution at C6Mark E Fraley, Justin T Steen, Edward J Brnardic, et al.Mabs|December 8, 2022
Developability profiling of a panel of Fc engineered SARS-CoV-2 neutralizing antibodiesAndrew Dippel, Austin Gallegos, Vineela Aleti, et al.Pageof 127